Search results
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Morningstar· 24 hours agoIn a lawsuit filed on Monday, the U.S. state alleges Pfizer made false statements about the safety of its COVID-19 vaccine and then worked ...
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 1 day agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company ...
Kansas AG sues Pfizer over 'misleading' COVID-19 vaccine claims
FOX 23 Maine· 2 days agoKansas Attorney General Kris Kobach announced Monday he is suing pharmaceutical giant Pfizer for...
Kansas attorney general sues Pfizer over marketing of COVID-19 vaccine
The Day· 1 day agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it...
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit By Reuters
Investing.com· 2 days agoIn a lawsuit filed in the District Court of Thomas County, the state said the New York-based...
Kansas Sues Pfizer Over Covid-19 Vaccine’s Safety, Efficacy
Bloomberg Law· 2 days agoPfizer said its vaccine would prevent the transmission of Covid-19, even though the company knew it never studied the effect of its & ...
Gateway - Quartz
Quartz· 8 hours agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According ...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka· 2 days agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 16 hours agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
Cantor Fitzgerald Reiterates “Overweight” Rating for Pfizer (NYSE:PFE)
ETF DAILY NEWS· 6 hours agoPfizer (NYSE:PFE – Get Free Report)‘s stock had its “overweight” rating reissued by equities researchers at Cantor Fitzgerald in a report issued on Monday, Benzinga reports ...